gemcitabine has been researched along with Burns in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Giacalone, N; Haar, L; James, L; Noel, G; Ogle, C; Osterburg, A; Schwemberger, S; Thomas, I; Wang, Q | 1 |
1 other study(ies) available for gemcitabine and Burns
Article | Year |
---|---|
A ribonucleotide reductase inhibitor reverses burn-induced inflammatory defects.
Topics: Animals; Burns; Concanavalin A; Deoxycytidine; Drug Evaluation, Preclinical; Gemcitabine; Interleukin-10; Interleukin-6; Leukocyte Count; Lipopolysaccharides; Lymphocyte Activation; Macrophages; Male; Mice; Mice, Inbred C57BL; Monocytes; Myeloid Cells; Nitric Oxide; Peptidoglycan; Pseudomonas Infections; Ribonucleotide Reductases; Spleen; T-Lymphocyte Subsets; Tumor Necrosis Factor-alpha | 2010 |